头孢他啶与头孢孟多治疗社区获得性肺炎的比较。
Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.
作者信息
Engle J C, Lifland P W, Schleupner C J
出版信息
Antimicrob Agents Chemother. 1985 Jul;28(1):146-8. doi: 10.1128/AAC.28.1.146.
Abstract
Ceftazidime and cefamandole were compared in the treatment of pneumonia. The median MIC of ceftazidime for all Streptococcus pneumoniae (n = 17) and Haemophilus influenzae (n = 10) isolates was 0.125 microgram/ml. All other isolates were inhibited by less than 0.5 microgram of ceftazidime per ml, with the exception of a group B streptococcus (MIC = 4 micrograms/ml). Satisfactory clinical responses were observed in 91% (20 of 22) of cefamandole-treated patients and 85% (17 of 20) of ceftazidime-treated patients.
摘要
对头孢他啶和头孢孟多治疗肺炎的效果进行了比较。头孢他啶对所有肺炎链球菌（n = 17）和流感嗜血杆菌（n = 10）分离株的MIC中位数为0.125微克/毫升。除1株B组链球菌（MIC = 4微克/毫升）外，所有其他分离株均被每毫升低于0.5微克的头孢他啶所抑制。头孢孟多治疗的患者中有91%（22例中的20例）观察到满意的临床反应，头孢他啶治疗的患者中有85%（20例中的17例）观察到满意的临床反应。
相似文献
1
Comparison of ceftazidime with cefamandole for therapy of community-acquired pneumonia.头孢他啶与头孢孟多治疗社区获得性肺炎的比较。
Antimicrob Agents Chemother. 1985 Jul;28(1):146-8. doi: 10.1128/AAC.28.1.146.
2
Comparative multicentre evaluation of the safety and efficacy of ceftazidime versus cefamandole for pneumonia.头孢他啶与头孢孟多治疗肺炎的安全性和有效性的多中心比较评估
J Antimicrob Chemother. 1986 Oct;18(4):521-9. doi: 10.1093/jac/18.4.521.
3
Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.氨苄西林/舒巴坦与头孢孟多治疗社区获得性肺炎的随机对照试验。
Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):293-8. doi: 10.1007/BF01974603.
4
Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia.头孢尼西与头孢孟多治疗社区获得性肺炎的对比试验。
Antimicrob Agents Chemother. 1982 Feb;21(2):231-5. doi: 10.1128/AAC.21.2.231.
5
Ceftazidime and cefamandole in the treatment of pneumonia.头孢他啶与头孢孟多治疗肺炎
J Antimicrob Chemother. 1983 Jul;12 Suppl A:27-30. doi: 10.1093/jac/12.suppl_a.27.
6
Cefamandole treatment of pulmonary infection caused by gram-negative rods.头孢孟多治疗革兰氏阴性杆菌引起的肺部感染。
Scand J Infect Dis Suppl. 1980;suppl 25:107-11.
7
A randomized trial of cefepime (BMY-28142) and ceftazidime for the treatment of pneumonia.头孢吡肟（BMY-28142）与头孢他啶治疗肺炎的随机试验
J Antimicrob Chemother. 1991 Oct;28(4):569-75. doi: 10.1093/jac/28.4.569.
8
Cefamandole vs. procaine penicillin for treatment of pneumonia due to Streptococcus pneumoniae: a random trial.
J Infect Dis. 1978 May;137 Suppl:S133-S138. doi: 10.1093/infdis/137.supplement.s133.
9
Clinical and laboratory investigation of cefamandole in infections of infants and children.头孢孟多用于婴幼儿感染的临床及实验室研究。
Antimicrob Agents Chemother. 1978 Jun;13(6):955-7. doi: 10.1128/AAC.13.6.955.
10
Clinical experience with cefamandole in pneumonia.头孢孟多治疗肺炎的临床经验。
Scand J Infect Dis Suppl. 1980;suppl 25:103-6.
引用本文的文献
1
Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.氨苄西林/舒巴坦与头孢孟多治疗社区获得性肺炎的随机对照试验。
Eur J Clin Microbiol Infect Dis. 1994 Apr;13(4):293-8. doi: 10.1007/BF01974603.
2
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.
3
Treatment of respiratory tract infections with cephalosporin antibiotics.用头孢菌素类抗生素治疗呼吸道感染。
Drugs. 1987;34 Suppl 2:180-204. doi: 10.2165/00003495-198700342-00014.
4
Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.氨苄西林与头孢孟多作为社区获得性肺炎初始治疗药物的比较
Antimicrob Agents Chemother. 1987 Jun;31(6):876-82. doi: 10.1128/AAC.31.6.876.
本文引用的文献
1
Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.头孢孟多，一种具有异常广泛活性谱的头孢菌素抗生素。
Antimicrob Agents Chemother. 1974 Aug;6(2):177-82. doi: 10.1128/AAC.6.2.177.
2
Cefoxitin, a semisynthetic cephamycin antibiotic: antibacterial spectrum and resistance to hydrolysis by gram-negative beta-lactamases.头孢西丁，一种半合成头孢霉素抗生素：抗菌谱及对革兰氏阴性β-内酰胺酶水解的抗性。
Antimicrob Agents Chemother. 1974 Aug;6(2):170-6. doi: 10.1128/AAC.6.2.170.
3
Comparative activities of 13 beta-lactam antibiotics.13种β-内酰胺类抗生素的比较活性
Antimicrob Agents Chemother. 1982 Jun;21(6):925-34. doi: 10.1128/AAC.21.6.925.
4
GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.GR 20263，一种具有抗假单胞菌活性的新型广谱头孢菌素。
Antimicrob Agents Chemother. 1980 May;17(5):876-83. doi: 10.1128/AAC.17.5.876.
5
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.GR - 20263：一种对假单胞菌属和肠杆菌科具有高活性的新型氨基噻唑基头孢菌素。
Antimicrob Agents Chemother. 1980 May;17(5):807-12. doi: 10.1128/AAC.17.5.807.
6
Oral or intravenous trimethoprim-sulfamethoxazole therapy for shigellosis.
Rev Infect Dis. 1982 Mar-Apr;4(2):546-50. doi: 10.1093/clinids/4.2.546.
7
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.八种β-内酰胺酶稳定型头孢菌素对产β-内酰胺酶革兰氏阴性杆菌的体外活性比较
Antimicrob Agents Chemother. 1981 Mar;19(3):407-13. doi: 10.1128/AAC.19.3.407.
8
The new beta-lactamase-stable cephalosporins.新型β-内酰胺酶稳定的头孢菌素。
Ann Intern Med. 1982 Sep;97(3):408-19. doi: 10.7326/0003-4819-97-3-408.
9
Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.头孢他啶的抗菌活性及β-内酰胺酶稳定性，一种对铜绿假单胞菌可能具有活性的氨噻唑基头孢菌素。
Antimicrob Agents Chemother. 1982 Jan;21(1):11-8. doi: 10.1128/AAC.21.1.11.
10
Comparative antipseudomonal activity of some newer beta-lactam agents.一些新型β-内酰胺类药物的抗假单胞菌活性比较
Antimicrob Agents Chemother. 1982 Feb;21(2):204-9. doi: 10.1128/AAC.21.2.204.
Zotero 插件